Skip to main content
. 2022 Jun 23;28(17):3742–3751. doi: 10.1158/1078-0432.CCR-22-0203

Table 2.

HDR (functional score) of BRCA2 missense DBD variants and ACMG framework classification.

ACMG codes Classification
Variant (p.) HDR Score PM1 PM5 PP1 PM3/BP2 PP3/BP4 (PROVEAN) BA1/BS1/PM2 (Frequency) BP5 PP_Multifac/BP_Multifac PS3/BS3 Pre-HDR Post-HDR
p.Val2908Gly 2.53 PM1 BP4 PM2 BS3 LBEN LBEN
p.Ser2522Phe 2.85 PM1 BP4 PM2 BS3 LBEN LBEN
p.Leu2972Trp 2.78 PM1 BP4 BS3 VUS LBEN
p.Gly2584Asp 2.79 PM1 BP4 PM2 BS3 VUS LBEN
p.Arg2494Gln 2.79 PM1 BP4 BS3 VUS LBEN
p.Arg2488Ser 2.96 PM1 BP4 PM2 BS3 VUS LBEN
p.Pro2771Leu 2.81 PM1 PP3 PM2 BS3 VUS VUS
p.Arg2488Gly 2.92 PM1 BP4 PM2 BS3 LBEN LBEN
p.Val2969Met 3.01 PM1 BP2 BP4 BS3 LBEN LBEN
p.Arg2787Cys 2.90 PM1 BP4 PM2 BS3-publishedb LBEN LBEN
p.Leu3011Pro 3.12 PM1 BP4 PM2 BS3 VUS LBEN
p.Ser2807Leu 3.04 PM1 BP4 PM2 BS3 VUS LBEN
p.Arg2973His 3.08 PM1 BP4 BP_Multifac BS3 LBEN LBEN
p.Pro2767Ser 3.05 PM1 BP4 PM2 BS3 VUS LBEN
p.Tyr3035Ser 3.10 PM1 BP2 BP4 BS3 LBEN LBEN
p.Gln3026Glu 3.06 PM1 BP4 PM2 BS3 VUS LBEN
p.Gly2508Ser 3.22 PM1 BP2 BP4 BS1_Supporting BS3 LBEN LBEN
p.Val3081Ala 3.22 PM1 BP4 PM2 BS3-publishedb LBEN LBEN
p.Pro2608Ala 3.47 PM1 BP4 PM2 BS3 VUS LBEN
p.Tyr3049Cys 3.32 PM1 BP4 PM2 BS3 VUS LBEN
p.Phe2600Cys 3.33 PM1 BP4 PM2 BS3 VUS LBEN
p.Ala2770Asp 3.51 PM1 BP4 PM2 BS3 VUS LBEN
p.Cys2646Trp 3.39 PM1 PP3 PM2 BS3 VUS VUS
p.Leu2768His 3.40 PM1 BP4 PM2 BS3 VUS LBEN
p.Cys2765Gly 3.41 PM1 PP3 PM2 BS3 VUS VUS
p.Cys3069Arg 3.52 PM1 BP4 PM2 BS3 VUS LBEN
p.Arg2520Pro 3.54 PM1 BP4 PM2 BS3 VUS LBEN
p.Phe2794Leu 3.56 PM1 BP4 PM2 BS3 VUS LBEN
p.Ile2495Thr 3.59 PM1 BP4 PM2 BS3-publishedb LBEN LBEN
p.Leu2587Phe 3.77 PM1 BP4 PM2 BS3 VUS LBEN
p.Tyr3092Cys 3.62 PM1 PP3 BP_Multifac BS3 LBEN LBEN
p.Ser3123Gly 3.72 PM1 BP4 PM2 BS3 VUS LBEN
p.Leu2929Trp 3.85 PM1 BP4 PM2 BS3-publishedb LBEN LBEN
p.Phe2873Cys 3.79 PM1 BP4 PM2 BS3-publishedb LBEN LBEN
p.Arg2991His 3.90 PM1 BP4 BS3-publishedb LBEN LBEN
p.Pro2639Ala 3.98 PM1 BP4 PM2 BS3-publishedb LBEN LBEN
p.Thr2662Met 3.89 PM1 BP4 PM2 BS3 VUS LBEN
p.Arg2625Lys 3.94 PM1 BP4 PM2 BS3 VUS LBEN
p.Glu2769Gln 3.97 PM1 BP4 PM2 BS3 VUS LBEN
p.Arg2787His 3.97 PM1 BP4 PM2 BS3-publishedb LBEN LBEN
p.Thr2515Ile 4.22 PM1 BP4 BP_Multifac BS3 LBEN LBEN
p.Asp2679Gly 4.12 PM1 BP4 PM2 BS3-publishedb LBEN LBEN
p.Ile2672Val 4.37 PM1 BP4 PM2 BS3-publishedb LBEN LBEN
p.Pro3039Leu 4.13 PM1 BP4 BS3-publishedb LBEN LBEN
p.Tyr3035Cys 4.16 PM1 BP4 BS3 VUS LBEN
p.Arg2520Gln 4.23 PM1 BP4 BS3-publishedb LBEN LBEN
p.Gly2901Asp 4.25 PM1 BP4 BS3-publisheda LBEN LBEN
p.Glu3071Asp 4.30 PM1 BP4 PM2 BS3-publishedb LBEN LBEN
p.Ile2490Thr 4.48 PM1 BP4 BA1 BS3-publishedb BEN BEN
p.Ser2810Gly 4.37 PM1 BP4 PM2 BS3 VUS LBEN
p.Arg2888Cys 4.57 PM1 BP2 BP4 BS3-publisheda LBEN LBEN
p.Leu2774Arg 4.41 PM1 BP4 PM2 BS3 VUS LBEN
p.Gly2544Ser 4.43 PM1 BP4 PM2 BS3 VUS LBEN
p.Ser2695Leu 4.45 PM1 BP2 BP4 PM2 BS3 LBEN LBEN
p.Leu2865Val 4.45 PM1 BP4 PM2 BS3-publishedb LBEN LBEN
p.Val2728Ala 4.49 PM1 BP4 PM2 BS3 VUS LBEN
p.Asp3170Gly 4.73 PM1 BP4 PM2 BS3-publishedb LBEN LBEN
p.Pro2735Arg 4.51 PM1 PP3 PM2 BS3 VUS VUS
p.Lys2849Glu 4.56 PM1 BP4 PM2 BS3-publishedb LBEN LBEN
p.Pro2827Ser 4.61 PM1 BP4 PM2 BS3 VUS LBEN
p.Asp2665Gly 4.74 PM1 BP4 BS3-publishedb LBEN LBEN
p.Ser2533Cys 4.64 PM1 BP4 PM2 BS3 VUS LBEN
p.Gln2561Arg 4.66 PM1 BP4 PM2 BS3 VUS LBEN
p.Gly3086Ala 4.73 PM1 BP4 BS3 VUS LBEN
p.Pro2785Leu 4.79 PM1 PP3 PM2 BS3 VUS VUS
p.Ser2704Phe 4.81 PM1 BP4 PM2 BS3-publisheda LBEN LBEN
p.Gln2858Arg 4.81 PM1 BP4 PM2 BP5 BS3 LBEN LBEN
p.Glu2981Lys 4.86 PM1 BP4 PM2 BS3 VUS LBEN
p.Val3079Ile 5.16 PM1 BP2 BP4 BS1_Supporting BS3-publisheda LBEN LBEN
p.Glu3152Lys 4.90 PM1 BP4 BP5 BS3 LBEN LBEN
p.Tyr3098His 5.31 PM1 BP4 BS1_Supporting BS3-publisheda LBEN LBEN
p.Arg2678Gly 5.12 PM1 BP4 PM2 BS3 VUS LBEN
p.Asp2913Glu 4.92 PM1 BP4 PM2 BS3-publishedb LBEN LBEN
p.Ser2806Leu 4.94 PM1 BP4 BS1_Supporting BS3 LBEN LBEN
p.Ala3029Val 4.95 PM1 BP4 PM2 BS3 VUS LBEN
p.Ala2756Gly 5.18 PM1 BP4 PM2 BS3 VUS LBEN
p.Ser3070Phe 5.00 PM1 BP4 PM2 BS3 VUS LBEN
p.Arg2502Cys 5.04 PM1 BP2 BP4 BS1_Supporting BP5 BS3 LBEN LBEN
p.Ser2483Asn 5.09 PM1 BP2 BP4 PM2 BS3 LBEN LBEN
p.Asp2965His 5.33 PM1 BP4 PM2 BS3-publishedb LBEN LBEN
p.Asp2712Asn 5.19 PM1 BP4 PM2 BS3 VUS LBEN
p.Gln2858Lys 5.23 PM1 BP4 PM2 BS3 VUS LBEN
p.Cys3069Gly 5.37 PM1 BP4 PM2 BS3 VUS LBEN
p.Ser2697Asn 5.39 PM1 BP2 BP4 BS3 LBEN LBEN
p.Lys2950Asn 5.41 PM1 BP4 BS1_Supporting BP5_Strong BS3 BEN BEN
p.Ile3107Thr 5.61 PM1 BP4 PM2 BS3 VUS LBEN
p.Glu2571Gly 5.50 PM1 BP4 BS3-publishedb LBEN LBEN
p.Asp3112Asn 5.67 PM1 BP4 PM2 BS3 VUS LBEN
p.Met2676Thr 5.66 PM1 BP4 PM2 BS3-publishedb LBEN LBEN

Note: PM1, protein structure; PM5, pathogenic effect for alteration of same residue; PM3, Fanconi anemia phenotype; BP2, healthy biallelic patients; PP1, cosegregation in family; BA1/BS1/PM2, Population Frequency Codes; BP5, Co, occurrence.

Abbreviations: BEN, Benign; CI, confidence interval; HDR, homology directed repair; LBEN, Likely Benign; LPATH, Likely Pathogenic; Multifac, Multi-factorial; P, Pathogenic; VUS, Variant of Uncertain Significance.

aBS3, published, previous classification using BS3/PS3 evidence from HDR assays published by the Couch laboratory.

bBS3, published, previously classified using BS3/PS3 evidence from functional studies by Couch and other laboratories (see Supplementary Table S2).